Infinity Pharmaceuticals Share Based Compensation Trend

INFI -- USA Stock  

USD 2.05  0.33  19.19%

This module enables investors to look at Infinity Pharmaceuticals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Cost of Revenue of 32.5 M, Gross Profit of 6 M or Interest Expense of 1.6 M, but also many exotic indicators such as Long Term Debt to Equity of 0.2339, PPandE Turnover of 5.4358 or Receivables Turnover of 1 K. This module is a perfect complement to use when analyzing Infinity Pharmaceuticals Valuation or Volatility. It can also complement various Infinity Pharmaceuticals Technical models. Please also check analysis of Infinity Pharmaceuticals Correlation with competitors.
Showing smoothed Share Based Compensation of Infinity Pharmaceuticals with missing and latest data points interpolated. A component of Net Cash Flow from Operations representing the total amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
Share Based Compensation10 Years Trend
Slightly volatile
 Share Based Compensation 

Regression Statistics

Arithmetic Mean  9,682,628
Geometric Mean  7,641,969
Coefficient Of Variation  51.53
Mean Deviation  4,314,054
Median  7,883,000
Standard Deviation  4,989,042
Range  16,792,619
R Value  0.96
R Squared  0.91
Significance  0.00000038
Slope  1,223,580

Infinity Pharmaceuticals Share Based Compensation Over Time

2016-12-31  14,700,000 
2017-12-31  14,700,000 
2018-12-31  17,294,118 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Upcoming Events

Infinity Pharmaceuticals Upcoming Company Events
Upcoming Quarterly ReportFebruary 28, 2017
Next Earnings ReportMay 3, 2017
Please also check analysis of Infinity Pharmaceuticals Correlation with competitors. Please also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.